Non-functioning pituitary macroadenomas: Benefit from early growth hormone substitution after surgery

被引:2
|
作者
Sauer, Nina [1 ]
Flitsch, Joerg [1 ]
Doeing, Inga [1 ]
Dannheim, Viola [1 ]
Burkhardt, Till [1 ]
Aberle, Jens [1 ]
机构
[1] Univ Klinikum Hamburg, D-20246 Hamburg, Germany
关键词
Pituitary macroadenoma; Growth hormone substitution; Metabolic benefit; Pituitary recovery; Benefit of health status;
D O I
10.1016/j.ghir.2014.03.001
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Purpose: Data suggests that substitution of GH in GH-deficient patients may improve quality-of-life and reduce insufficiency-associated-symptoms. Unlike in corticotroph, thyreotroph, or gonadotroph-insufficiency, GH-substitution is usually not started within the first 6-12 months after surgery. We aimed to investigate the effect of early-GH-substitution on body-composition, metabolic and pituitary-laboratory-tests, and quality-of-life. Methods: Data was reviewed from 21 adult-patients who were diagnosed with insufficiency of GH-axis using insulin-hypoglycemia-test. We retrospectively assessed body-composition, metabolic and pituitary-laboratory-tests and quality-of-life for a period of 52-weeks after pituitary-surgery in patients with early GH-substitution (= treated-group, 11-patients) and no GH-substitution (= untreated group, 10-patients). Results: Follow-up-IGF-I-levels of the treated-group stayed within the normal range and differed significantly from the untreated-group. Bioelectrical-impedance-analysis showed a significant decrease of impedance, a significant increase of lean-body-mass and a significant difference in health status in the treated group (p < 0.05). Average increase in HDL-level was 2.1 mg/dl in the untreated compared to an average decrease of 0.2 mg/dl in the treated-group. Lp(a)-levels were reduced by 4.1 mg/dl in the treated and by 2.7 mg/dl in the untreated-group. Both groups showed an initial-mean-life-satisfaction below average (-0.9 and -1.2). Within one year after surgery mean-health-status improved in both groups. The difference in health-status after 1-year compared to the health-status of the previous year was statistically different between both groups with a greater benefit in the treated-group. Finally there was a trend detectably pointing towards an improvement in pituitary-function (LH- and FSH-recovery) if GH was substituted. Conclusion: Early GH-substitution leads to a significant improvement in quality-of-life and body-composition after pituitary-surgery. It is possible that pituitary-function recovers more with early-GH-substitution. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:71 / 75
页数:5
相关论文
共 50 条
  • [1] Non-functioning pituitary macroadenomas: Benefit from early growth hormone substitution after surgery
    Sauer, N.
    Flitsch, J.
    Doeing, I.
    Dannheim, V.
    Aberle, J.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2013, 121 (03)
  • [2] Clinically non-functioning pituitary macroadenomas in the elderly
    Del Monte, Patrizia
    Foppiani, Luca
    Ruelle, Antonio
    Andrioli, Giancarlo
    Bandelloni, Roberto
    Quilici, Paolo
    Prete, Camilla
    Palummeri, Ernesto
    Marugo, Alessandro
    Bernasconi, Donatella
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2007, 19 (01) : 34 - 40
  • [3] The natural course of non-functioning pituitary macroadenomas
    Dekkers, O. M.
    Hammer, S.
    de Keizer, R. J. W.
    Roelfsema, F.
    Schutte, P. J.
    Smit, J. W. A.
    Romijn, J. A.
    Pereira, A. M.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007, 156 (02) : 217 - 224
  • [4] The impact of transsphenoidal surgery on pituitary function in patients with non-functioning macroadenomas
    Maria Mavromati
    Thomas Mavrakanas
    François R. Jornayvaz
    Karl Schaller
    Aikaterini Fitsiori
    Maria I. Vargas
    Johannes A. Lobrinus
    Doron Merkler
    Kristof Egervari
    Jacques Philippe
    Sophie Leboulleux
    Shahan Momjian
    Endocrine, 2023, 81 : 340 - 348
  • [5] Clinically non-functioning pituitary macroadenomas in the elderly
    Patrizia Del Monte
    Luca Foppiani
    Antonio Ruelle
    Giancarlo Andrioli
    Roberto Bandelloni
    Paolo Quilici
    Camilla Prete
    Ernesto Palummeri
    Alessandro Marugo
    Donatella Bernasconi
    Aging Clinical and Experimental Research, 2007, 19 : 34 - 40
  • [6] The prevalence of hyperprolactinemia in non-functioning pituitary macroadenomas
    Zhang, Fangfang
    Huang, Yinxing
    Ding, Chenyu
    Huang, Guoliang
    Wang, Shousen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (10): : 18990 - 18997
  • [7] The impact of transsphenoidal surgery on pituitary function in patients with non-functioning macroadenomas
    Mavromati, Maria
    Mavrakanas, Thomas
    Jornayvaz, Francois R.
    Schaller, Karl
    Fitsiori, Aikaterini
    Vargas, Maria I.
    Lobrinus, Johannes A.
    Merkler, Doron
    Egervari, Kristof
    Philippe, Jacques
    Leboulleux, Sophie
    Momjian, Shahan
    ENDOCRINE, 2023, 81 (02) : 340 - 348
  • [8] Cabergoline treatment for surgery-naïve non-functioning pituitary macroadenomas
    Ayalon-Dangur, Irit
    Turjeman, Adi
    Hirsch, Dania
    Robenshtok, Eyal
    Tsvetov, Gloria
    Gorshtein, Alexander
    Masri, Hiba
    Shraga-Slutzky, Ilana
    Manisterski, Yossi
    Akirov, Amit
    Shimon, Ilan
    PITUITARY, 2024, 27 (01) : 52 - 60
  • [9] Regrowth of non-functioning pituitary macroadenomas undergoing surgery in a single Australian centre
    Watts, Anna
    McNeill, Peter
    Inder, Warrick
    Wang, Yi Yuen
    Caputo, Carmela
    CLINICAL ENDOCRINOLOGY, 2016, 84 : 42 - 42
  • [10] Cabergoline treatment for surgery-naïve non-functioning pituitary macroadenomas
    Irit Ayalon-Dangur
    Adi Turjeman
    Dania Hirsch
    Eyal Robenshtok
    Gloria Tsvetov
    Alexander Gorshtein
    Hiba Masri
    Ilana Shraga-Slutzky
    Yossi Manisterski
    Amit Akirov
    Ilan Shimon
    Pituitary, 2024, 27 : 52 - 60